News
Projects
Orgs
Project
Articles 8
Votes 0
Lilly.com

Authors 3

Investors
Eli Lilly
Company
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders - Eli Lilly
3d
An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 - Eli Lilly and Company
22d
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight - Eli Lilly
3mo
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases - Eli Lilly
3mo
Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial - Eli Lilly
4mo
FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company - Investors | Eli Lilly and Company
>2y
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology | Eli Lilly and Company - Investors | Eli Lilly and Company
almost3y
Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease | Eli Lilly and Company - Investors | Eli Lilly and Company
almost3y